Drug · DIN 02516233
ABECMA
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since November 14, 2023.
- Drug Identification Number (DIN)
- 02516233
- Company (DIN owner)
- Celgene IncSaint-Laurent, Quebec, Canada
- Schedule
- Schedule D; Prescription
- Dosage form
- Suspension
- Route
- Intravenous
- Therapeutic class (ATC)
- Idecabtagene vicleucel L01XL07
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| IDECABTAGENE VICLEUCEL | 520000000 CELLS |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 26, 2021: NOC 25936New Drug Submission (NDS)